Patients with refractory cardiogenic shock can benefit from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The use of levosimendan in VA-ECMO patients may facilitate weaning and enhance survival.
Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis
Bertini, Pietro;Falcone, Marco;Costanzo, Diego;Brizzi, Giulia;Romani, Matteo;Guarracino, Fabio
2022-01-01
Abstract
Patients with refractory cardiogenic shock can benefit from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The use of levosimendan in VA-ECMO patients may facilitate weaning and enhance survival.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
